Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies.

Shi J, van Veelen PA, Mahler M, Janssen GM, Drijfhout JW, Huizinga TW, Toes RE, Trouw LA.

Autoimmun Rev. 2014 Mar;13(3):225-30. doi: 10.1016/j.autrev.2013.10.008. Epub 2013 Oct 28. Review.

PMID:
24176675
2.

Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis.

Shi J, van de Stadt LA, Levarht EW, Huizinga TW, Toes RE, Trouw LA, van Schaardenburg D.

Arthritis Rheum. 2013 Apr;65(4):911-5. doi: 10.1002/art.37830.

3.

Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis.

Stoop JN, Liu BS, Shi J, Jansen DT, Hegen M, Huizinga TW, Trouw LA, Toes RE.

PLoS One. 2014 Jul 15;9(7):e102163. doi: 10.1371/journal.pone.0102163. eCollection 2014.

4.

Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.

Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GM, van Veelen PA, Levarht NE, van der Helm-van Mil AH, Cerami A, Huizinga TW, Toes RE, Trouw LA.

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17372-7. doi: 10.1073/pnas.1114465108. Epub 2011 Oct 10.

5.

Autoimmunity in rheumatoid arthritis: different antigens--common principles.

Trouw LA, Huizinga TW, Toes RE.

Ann Rheum Dis. 2013 Apr;72 Suppl 2:ii132-6. doi: 10.1136/annrheumdis-2012-202349. Epub 2012 Dec 19. Review.

PMID:
23253931
6.

The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis.

Shi J, van Steenbergen HW, van Nies JA, Levarht EW, Huizinga TW, van der Helm-van Mil AH, Toes RE, Trouw LA.

Arthritis Res Ther. 2015 Nov 24;17:339. doi: 10.1186/s13075-015-0860-6.

7.

Breach of autoreactive B cell tolerance by post-translationally modified proteins.

Dekkers JS, Verheul MK, Stoop JN, Liu B, Ioan-Facsinay A, van Veelen PA, de Ru AH, Janssen GMC, Hegen M, Rapecki S, Huizinga TWJ, Trouw LA, Toes REM.

Ann Rheum Dis. 2017 Aug;76(8):1449-1457. doi: 10.1136/annrheumdis-2016-210772. Epub 2017 Apr 25.

PMID:
28442530
8.

Protein carbamylation in kidney disease: pathogenesis and clinical implications.

Kalim S, Karumanchi SA, Thadhani RI, Berg AH.

Am J Kidney Dis. 2014 Nov;64(5):793-803. doi: 10.1053/j.ajkd.2014.04.034. Epub 2014 Jul 16. Review.

9.

Identification of carbamylated alpha 1 anti-trypsin (A1AT) as an antigenic target of anti-CarP antibodies in patients with rheumatoid arthritis.

Verheul MK, Yee A, Seaman A, Janssen GM, van Veelen PA, Drijfhout JW, Toes REM, Mahler M, Trouw LA.

J Autoimmun. 2017 Jun;80:77-84. doi: 10.1016/j.jaut.2017.02.008. Epub 2017 Mar 11.

PMID:
28291659
10.

Post-translational modifications in rheumatoid arthritis and atherosclerosis: Focus on citrullination and carbamylation.

Spinelli FR, Pecani A, Conti F, Mancini R, Alessandri C, Valesini G.

J Int Med Res. 2016 Sep;44(1 suppl):81-84.

PMID:
27683146
11.

Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients.

Spinelli FR, Pecani A, Ciciarello F, Colasanti T, Di Franco M, Miranda F, Conti F, Valesini G, Alessandri C.

BMC Musculoskelet Disord. 2017 May 25;18(1):214. doi: 10.1186/s12891-017-1563-8. Erratum in: BMC Musculoskelet Disord. 2017 Jun 16;18(1):263.

12.

Impaired biological activity of erythropoietin by cyanate carbamylation.

Mun KC, Golper TA.

Blood Purif. 2000;18(1):13-7.

PMID:
10686438
13.

Carbamylation differentially alters type I collagen sensitivity to various collagenases.

Jaisson S, Larreta-Garde V, Bellon G, Hornebeck W, Garnotel R, Gillery P.

Matrix Biol. 2007 Apr;26(3):190-6. Epub 2006 Nov 10.

PMID:
17156988
14.

Endogenous carbamylation of renal medullary proteins.

Claxton JS, Sandoval PC, Liu G, Chou CL, Hoffert JD, Knepper MA.

PLoS One. 2013 Dec 26;8(12):e82655. doi: 10.1371/journal.pone.0082655. eCollection 2013.

15.

Auto-reactions, autoimmunity and psoriatic arthritis.

Chimenti MS, Triggianese P, Nuccetelli M, Terracciano C, Crisanti A, Guarino MD, Bernardini S, Perricone R.

Autoimmun Rev. 2015 Dec;14(12):1142-6. doi: 10.1016/j.autrev.2015.08.003. Epub 2015 Aug 5. Review.

PMID:
26254734
16.

Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis.

Jaisson S, Pietrement C, Gillery P.

Clin Chem. 2011 Nov;57(11):1499-505. doi: 10.1373/clinchem.2011.163188. Epub 2011 Jul 18. Review.

17.

Protein carbamylation links inflammation, smoking, uremia and atherogenesis.

Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Hörkkö S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA, Hazen SL.

Nat Med. 2007 Oct;13(10):1176-84. Epub 2007 Sep 9.

PMID:
17828273
18.

Protein carbamylation and cardiovascular disease.

Verbrugge FH, Tang WH, Hazen SL.

Kidney Int. 2015 Sep;88(3):474-8. doi: 10.1038/ki.2015.166. Epub 2015 Jun 10. Review.

19.

Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.

Trouw LA, Rispens T, Toes REM.

Nat Rev Rheumatol. 2017 Jun;13(6):331-339. doi: 10.1038/nrrheum.2017.15. Epub 2017 Mar 9. Review.

PMID:
28275265
20.

Protein carbamylation: in vivo modification or in vitro artefact?

Kollipara L, Zahedi RP.

Proteomics. 2013 Mar;13(6):941-4. doi: 10.1002/pmic.201200452.

PMID:
23335428

Supplemental Content

Support Center